BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Frazzoni M, De Micheli E, Zentilin P, Savarino V. Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn. Aliment Pharmacol Ther. 2004;20:81-88. [PMID: 15225174 DOI: 10.1111/j.1365-2036.2004.01998.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Garrigues V, Ponce J. Aspectos menos conocidos de la enfermedad por reflujo gastroesofágico: pirosis funcional y reflujo no ácido. Gastroenterología y Hepatología 2008;31:522-9. [DOI: 10.1157/13127096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Talley NJ, Armstrong D, Junghard O, Wiklund I. Predictors of treatment response in patients with non-erosive reflux disease. Aliment Pharmacol Ther 2006;24:371-6. [DOI: 10.1111/j.1365-2036.2006.02983.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
3 Lee YC, Wang HP, Chiu HM, Huang SP, Liao SC, Chen MF, Lin JT, Wu MS. GABRA6 genetic polymorphism is associated with the risk of functional heartburn in Chinese. J Gastroenterol Hepatol. 2007;22:227-233. [PMID: 17295876 DOI: 10.1111/j.1440-1746.2006.04441.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
4 Frazzoni M, Conigliaro R, Colli G, Melotti G. Conventional versus robot-assisted laparoscopic Nissen fundoplication: a comparison of postoperative acid reflux parameters. Surg Endosc. 2012;26:1675-1681. [PMID: 22179476 DOI: 10.1007/s00464-011-2091-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
5 Hachem C, Shaheen NJ. Diagnosis and Management of Functional Heartburn. Am J Gastroenterol 2016;111:53-61; quiz 62. [PMID: 26729546 DOI: 10.1038/ajg.2015.376] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
6 Aguero GC, Lemme EM, Alvariz A, Carvalho BB, Schechter RB, Abrahão L Jr. [Prevalence of supraesophageal manifestations in patients with gastroesophageal erosive and non-erosive reflux disease]. Arq Gastroenterol 2007;44:39-43. [PMID: 17639181 DOI: 10.1590/s0004-28032007000100009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Bredenoord AJ, Smout AJ. Refractory gastrooesophageal reflux disease: . European Journal of Gastroenterology & Hepatology 2008;20:217-23. [DOI: 10.1097/meg.0b013e3282f1cc39] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
8 Martinucci I, Bortoli N, Giacchino M, Bodini G, Marabotto E, Marchi S, Savarino V, Savarino E. Esophageal motility abnormalities in gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther 2014; 5(2): 86-96 [PMID: 24868489 DOI: 10.4292/wjgpt.v5.i2.86] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
9 Park E, Choi M, Baeg M, Lim C, Kim J, Cho Y, Park J, Lee I, Kim S, Choi K. The Value of Early Wireless Esophageal pH Monitoring in Diagnosing Functional Heartburn in Refractory Gastroesophageal Reflux Disease. Dig Dis Sci 2013;58:2933-9. [DOI: 10.1007/s10620-013-2728-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
10 Savarino E, Gemignani L, Pohl D, Zentilin P, Dulbecco P, Assandri L, Marabotto E, Bonfanti D, Inferrera S, Fazio V. Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34:476-486. [PMID: 21671968 DOI: 10.1111/j.1365-2036.2011.04742.x] [Cited by in Crossref: 122] [Cited by in F6Publishing: 99] [Article Influence: 11.1] [Reference Citation Analysis]
11 Hsu YC, Yang TH, Hsu WL, Wu HT, Cheng YC, Chiang MF, Wang CS, Lin HJ. Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis. Br J Clin Pharmacol. 2010;70:171-179. [PMID: 20653670 DOI: 10.1111/j.1365-2125.2010.03696.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
12 Bazin C, Benezech A, Alessandrini M, Grimaud JC, Vitton V. Esophageal Motor Disorders Are a Strong and Independant Associated Factor of Barrett's Esophagus. J Neurogastroenterol Motil 2018;24:216-25. [PMID: 29605977 DOI: 10.5056/jnm17090] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
13 Ravi K, Katzka DA. Esophageal Impedance Monitoring: Clinical Pearls and Pitfalls. Am J Gastroenterol 2016;111:1245-56. [PMID: 27325223 DOI: 10.1038/ajg.2016.256] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
14 Frazzoni M, Manno M, De Micheli E, Savarino V. Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors. Digestive and Liver Disease 2007;39:415-21. [DOI: 10.1016/j.dld.2007.01.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
15 Frazzoni M, Piccoli M, Conigliaro R, Frazzoni L, Melotti G. Laparoscopic fundoplication for gastroesophageal reflux disease. World J Gastroenterol 2014; 20(39): 14272-14279 [PMID: 25339814 DOI: 10.3748/wjg.v20.i39.14272] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 24] [Article Influence: 5.1] [Reference Citation Analysis]
16 Conchillo JM, Schwartz MP, Selimah M, Samsom M, Sifrim D, Smout AJ. Acid and non-acid reflux patterns in patients with erosive esophagitis and non-erosive reflux disease (NERD): a study using intraluminal impedance monitoring. Dig Dis Sci. 2008;53:1506-1512. [PMID: 17934853 DOI: 10.1007/s10620-007-0059-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
17 Tolone S, Savarino E, Zaninotto G, Gyawali CP, Frazzoni M, de Bortoli N, Frazzoni L, Del Genio G, Bodini G, Furnari M, Savarino V, Docimo L. High-resolution manometry is superior to endoscopy and radiology in assessing and grading sliding hiatal hernia: A comparison with surgical in vivo evaluation. United European Gastroenterol J 2018;6:981-9. [PMID: 30228885 DOI: 10.1177/2050640618769160] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 8.5] [Reference Citation Analysis]
18 Patel D, Fass R, Vaezi M. Untangling Nonerosive Reflux Disease From Functional Heartburn. Clin Gastroenterol Hepatol 2021;19:1314-26. [PMID: 32246998 DOI: 10.1016/j.cgh.2020.03.057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kohata Y, Fujiwara Y, Machida H, Okazaki H, Yamagami H, Tanigawa T, Watanabe K, Watanabe T, Tominaga K, Arakawa T. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring. J Gastroenterol Hepatol. 2012;27 Suppl 3:58-62. [PMID: 22486873 DOI: 10.1111/j.1440-1746.2012.07074.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
20 Aben-athar C, Dantas R. Primary and secondary esophageal contractions in patients with gastroesophageal reflux disease. Braz J Med Biol Res 2006;39:1027-31. [DOI: 10.1590/s0100-879x2006000800005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
21 Omura N, Kashiwagi H, Yano F, Tsuboi K, Ishibashi Y, Kawasaki N, Suzuki Y, Yanaga K. Therapeutic effects of laparoscopic fundoplication for nonerosive gastroesophageal reflux disease. Surg Today 2006;36:954-60. [PMID: 17072714 DOI: 10.1007/s00595-006-3287-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
22 Hershcovici T, Zimmerman J. Functional heartburn vs. non-erosive reflux disease: similarities and differences. Aliment Pharmacol Ther. 2008;27:1103-1109. [PMID: 18315589 DOI: 10.1111/j.1365-2036.2008.03666.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
23 Frazzoni M, Conigliaro R, Mirante VG, Melotti G. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn. Neurogastroenterol Motil. 2012;24:141-146, e87. [PMID: 21988704 DOI: 10.1111/j.1365-2982.2011.01800.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
24 Zentilin P, Savarino V, Mastracci L, Spaggiari P, Dulbecco P, Ceppa P, Savarino E, Parodi A, Mansi C, Fiocca R. Reassessment of the Diagnostic Value of Histology in Patients with GERD, Using Multiple Biopsy Sites and an Appropriate Control Group. Am J Gastroenterology 2005;100:2299-306. [DOI: 10.1111/j.1572-0241.2005.50209.x] [Cited by in Crossref: 143] [Cited by in F6Publishing: 132] [Article Influence: 8.4] [Reference Citation Analysis]
25 Thoua NM, Khoo D, Kalantzis C, Emmanuel AV. Acid-related oesophageal sensitivity, not dysmotility, differentiates subgroups of patients with non-erosive reflux disease: ACID SENSITIVITY IN NERD. Alimentary Pharmacology & Therapeutics 2008;27:396-403. [DOI: 10.1111/j.1365-2036.2007.03584.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
26 Tack J. Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease. Curr Opin Gastroenterol. 2005;21:454-460. [PMID: 15930988 DOI: 10.1097/01.mog.0000166657.09968.4b] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Fass R. Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure. Drugs. 2007;67:1521-1530. [PMID: 17661525 DOI: 10.2165/00003495-200767110-00001] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 4.5] [Reference Citation Analysis]
28 Peura DA, Pilmer B, Hunt B, Mody R, Perez MC. The effects of increasing body mass index on heartburn severity, frequency and response to treatment with dexlansoprazole or lansoprazole. Aliment Pharmacol Ther. 2013;37:810-818. [PMID: 23451835 DOI: 10.1111/apt.12270] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
29 Navarro-rodriguez T, Fass R. Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions—A debate: Pro. Curr Treat Options Gastro 2007;10:294-304. [DOI: 10.1007/s11938-007-0072-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
30 Hiyama T, Matsuo K, Urabe Y, Fukuhara T, Tanaka S, Yoshihara M, Haruma K, Chayama K. Meta-analysis used to identify factors associated with the effectiveness of proton pump inhibitors against non-erosive reflux disease. J Gastroenterol Hepatol. 2009;24:1326-1332. [PMID: 19702900 DOI: 10.1111/j.1440-1746.2009.05879.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
31 Fass R, Dickman R. Functional heartburn: misdiagnosed gastroesophageal reflux or a distinct entity? Nat Rev Gastroenterol Hepatol 2005;2:120-1. [DOI: 10.1038/ncpgasthep0113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
32 Fass R. Functional heartburn: what it is and how to treat it. Gastrointest Endosc Clin N Am 2009;19:23-33, v. [PMID: 19232278 DOI: 10.1016/j.giec.2008.12.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
33 Zentilin P, Iiritano E, Dulbecco P, Bilardi C, Savarino E, De Conca S, Parodi A, Reglioni S, Vigneri S, Savarino V. Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Digestive and Liver Disease 2006;38:226-32. [DOI: 10.1016/j.dld.2005.12.011] [Cited by in Crossref: 118] [Cited by in F6Publishing: 104] [Article Influence: 7.4] [Reference Citation Analysis]
34 Savarino E, Giacchino M, Savarino V. Dysmotility and reflux disease. Curr Opin Otolaryngol Head Neck Surg. 2013;21:548-556. [PMID: 24240131 DOI: 10.1097/moo.0b013e3283658edf] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
35 Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease--where next? Aliment Pharmacol Ther. 2005;22:79-94. [PMID: 16011666 DOI: 10.1111/j.1365-2036.2005.02531.x] [Cited by in Crossref: 275] [Cited by in F6Publishing: 250] [Article Influence: 16.2] [Reference Citation Analysis]
36 Zhang M, Chen M, Peng S, Xiao Y. The Rome IV versus Rome III criteria for heartburn diagnosis: A comparative study. United European Gastroenterol J 2018;6:358-66. [PMID: 29774149 DOI: 10.1177/2050640617735084] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
37 Dickman R, Fass R. Functional heartburn. Curr Treat Options Gastroenterol 2005;8:285-91. [PMID: 16009029 DOI: 10.1007/s11938-005-0021-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
38 Wu JC, Lai LH, Chow DK, Wong GL, Sung JJ, Chan FK. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease. Neurogastroenterol Motil. 2011;23:155-160, e31. [PMID: 21087355 DOI: 10.1111/j.1365-2982.2010.01627.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
39 Long JD, Orlando RC. Nonerosive reflux disease: A pathophysiologic perspective. Curr Gastroenterol Rep 2008;10:200-7. [DOI: 10.1007/s11894-008-0044-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
40 Frazzoni M, Manta R, Mirante VG, Conigliaro R, Frazzoni L, Melotti G. Esophageal chemical clearance is impaired in gastro-esophageal reflux disease--a 24-h impedance-pH monitoring assessment. Neurogastroenterol Motil. 2013;25:399-406, e295. [PMID: 23360178 DOI: 10.1111/nmo.12080] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 9.2] [Reference Citation Analysis]